Cardiovascular Abnormalities, Hemodynamic Instability, Respiratory Abnormalities
Conditions
Keywords
Point Of Care Ultrasonography, Soroka University Medical Center, Heart Failure, cardiovascular
Brief summary
This is a Prospective, Double-center, randomized clinical trial. The purpose of the trial is to evaluate the benefit of adding POC US to the management of inpatients admitted to the internal ward with respiratory, cardiovascular or hemodynamic abnormalities.
Detailed description
This is a Prospective, Double-center, randomized clinical trial. The purpose of the trial is to evaluate the benefit of adding POC US to the management of inpatients admitted to the internal ward with respiratory, cardiovascular or hemodynamic abnormalities. This is a stage 1 pilot trial aimed to provide better understanding on the study population and study groups. This trial will comprise a total of 60 patients, 30 subjects on the intervention group and an equal number on the control group. The results of this pilot trial will be to design a larger trial and calculate a required sample size.
Interventions
Examination with an ultrasound machine
Sponsors
Study design
Eligibility
Inclusion criteria
1. Patients admitted to internal ward 2. Age ≥ 18 3. No previous internal ward admission within the last 6 months 4. At least one symptom or sign of the following on admission: * Respiratory abnormalities: Dyspnea, RR\>20, O2 SAT\<90% requirement of oxygen or non-invasive ventilation or mechanical ventilation * Cardiovascular abnormalities: Chest pain, HR\>100, new/worsening peripheral edema, newly diagnosed ECG changes * Hemodynamic instability: SBP\<90 mmHg or on vasopressor infusion or pre-renal azotemia
Exclusion criteria
1. Patients with cognitive impairment or cannot sign informed consent. 2. Subject enrolled in a different study 3. Patients with end stage disease receiving Palliative/end of life treatments. 4. Pregnant patients. 5. Patients that were given a consult by one of the research members pre enrollment 6. Patient under responsibility of one of the study team members
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Length of hospitalization | 1 month |
Secondary
| Measure | Time frame |
|---|---|
| Readmission rates | 15 months |
Countries
Israel